Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis
Journal of Clinical Oncology · 01.03.2023 · 41 (7) · 1393-1403
DOI: 10.1200/jco.22.00643 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of Clinical Oncology, erschienen am 01.03.2023. Verfasst von Eli Muchtar und 26 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology, Mayo Clinic, Rochester, MN. Hauptthemen laut MEDLINE: Amyloidosis, Immunoglobulin Light-chain Amyloidosis. Die Arbeit wurde bisher 99-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
PURPOSE Binary cardiac response assessment using cardiac biomarkers is prognostic in light chain amyloidosis. Previous studies suggested four-level cardiac responses using N-terminal prohormone of brain natiuretic peptide improves prognostic prediction. This study was designed to validate graded cardiac response criteria using N-terminal prohormone of brain natiuretic peptide/brain natiuretic peptide. PATIENTS AND METHODS This retrospective, multicenter study included patients with light chain amyloidosis who achieved at least a hematologic partial response (PR) and were evaluable for cardiac response. Four response criteria were tested on the basis of natriuretic peptide response depth: cardiac complete response (CarCR), cardiac very good partial response (CarVGPR), cardiac PR (CarPR), and cardiac no response (CarNR). Response was classified as best response and at fixed time points (6, 12, and 24 months from therapy initiation). The study primary outcome was overall survival. RESULTS 651 patients were included. Best CarCR, CarVGPR, CarPR, and CarNR were achieved in 16%, 26.4%, 22.9%, and 34.7% of patients, respectively. Patients in cardiac stage II were more likely to achieve CarCR than patients in cardiac stage IIIA and IIIB (22% v 13.5% v 3.2%; P < .001). A deeper cardiac response was associated with a longer survival (5-year overall survival 93%, 79%, 65%, and 33% for CarCR, CarVGPR, CarPR, and CarNR, respectively; P < .001). Fixed time-point analyses and time-varying covariates Cox regression analysis, to minimize survivorship bias, affirmed the independent survival advantage of deeper cardiac responses. Four-level response performed better than two-level response as early as 12 months from therapy initiation. CONCLUSION Graded cardiac response criteria allow better assessment of cardiac improvement compared with the traditional binary response system. The study re-emphasizes the importance of early diagnosis, which increases the likelihood of deep cardiac responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Hematology, Mayo Clinic, Rochester, MN.
- National Amyloidosis Centre, University College London, Royal Free Hospital Campus, London, United Kingdom.
- Amyloidosis Research and Treatment Center, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
- Department of Molecular Medicine, University of Pavia, Pavia, Italy.
- Medical Department V, Amyloidosis Center, University of Heidelberg, Heidelberg, Germany.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Rochester, MN.
ORCID-Profile: Eli Muchtar, Angela Dispenzieri, Giovanni Palladini, Paolo Milani, Giampaolo Merlini, Stefan Schönland, Ute Hegenbart, Shaji K Kumar, Efstathios Kastritis, Meletios A Dimopoulos, Michaela Liedtke, Vaishali Sanchorawala, Heather Landau, Suzanne Lentzsch, Morie A Gertz
Förderung
- NCI NIH HHS
Zitieren
APA
Muchtar, E., Dispenzieri, A., Wisniowski, B., Palladini, G., Milani, P., Merlini, G., Schönland, S., Veelken, K., Hegenbart, U., Geyer, S. M., Kumar, S. K., Kastritis, E., Dimopoulos, M. A., Liedtke, M., Witteles, R., Sanchorawala, V., Szalat, R., Landau, H., Petrlik, E., …, & Gertz, M. A. (2023). Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of Clinical Oncology, 41(7), 1393-1403. https://doi.org/10.1200/jco.22.00643
Vancouver
Muchtar E, Dispenzieri A, Wisniowski B, Palladini G, Milani P, Merlini G, et al. Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis. Journal of Clinical Oncology. 2023;41(7):1393-1403. doi:10.1200/jco.22.00643
BibTeX
@article{Muchtar2023,
author = {Muchtar, Eli and Dispenzieri, Angela and Wisniowski, Brendan and Palladini, Giovanni and Milani, Paolo and Merlini, Giampaolo and Schönland, Stefan and Veelken, Kaya and Hegenbart, Ute and Geyer, Susan M and Kumar, Shaji K and Kastritis, Efstathios and Dimopoulos, Meletios A and Liedtke, Michaela and Witteles, Ronald and Sanchorawala, Vaishali and Szalat, Raphael and Landau, Heather and Petrlik, Erica and Lentzsch, Suzanne and Coltoff, Alexander and Bladé, Joan and Cibeira, Maria Teresa and Cohen, Oliver and Foard, Darren and Wechalekar, Ashutosh and Gertz, Morie A},
title = {Graded Cardiac Response Criteria for Patients With Systemic Light Chain Amyloidosis},
journal = {Journal of Clinical Oncology},
year = {2023},
volume = {41},
number = {7},
pages = {1393--1403},
doi = {10.1200/jco.22.00643}
}
EUVIMED